Request a   Quote

Company

Newsroom

Flexan LLC acquires MEDRON Inc. to expand contract manufacturing capabilities

Posted by Flexan

12/5/16 2:28 PM

flexan proud logo.pngCHICAGO, Illinois (December 2, 2016) – Flexan LLC, wholly owned subsidiary of Flexan Medical Holdings, LLC, a leading global custom rubber molding company, announced today the acquisition of MEDRON Inc, a medical device contract manufacturing services company based in Salt Lake City, Utah. 

“We are excited to add MEDRON’s vast array of capabilities to our custom medical molding services” said Jim Fitzgerald, President & CEO of Flexan Medical Holdings.  “MEDRON’s reputation for providing high quality products from design to product launch and ongoing manufacturing support aligns well with our platform of providing long-term and short-term implantable silicone components. We are excited about the combination of our great brands, and our great people.” This acquisition supports the current trend of the medical device industry’s strategic efforts to outsource with total solution providers who can consolidate critical offerings to address the needs of the global device market. 

“We are thrilled to partner with Flexan,” said Ron Wortley, President of MEDRON.  “The combined diversity of offerings along with strong technical management teams will bring significant value to our existing and new customers.  Both organizations have similar cultures; each has a tremendous focus on innovation while delivering high quality products and the desire to help address serious clinical needs for our customers and ultimately the patient”, noted Mr. Wortley.  MEDRON has gained a significant reputation for creating solutions in a wide range of therapeutic areas from design and development, molding, assembly to final packaging and sterilization.

“The addition of MEDRON significantly enhances our contract manufacturing service offerings through the combination of world class elastomer component molding, device design, secondary operation services, and diversified global manufacturing locations”, said Ron Labrum, Linden Operating Partner. “Furthermore, it is our strategic imperative to continue to invest in our service offerings for our global customers.”  Mr. Labrum serves as Chairman of Flexan Medical Holdings, LLC.

Flexan Medical Holdings, LLC is a portfolio company of Linden Capital Partners.

About Flexan Medical Holdings, LLC

Founded in 1946, Flexan is a leading global manufacturer of high-precision elastomer parts that are critical components in a broad array of products and industry applications. Headquartered in Chicago, IL, Flexan has over 500 employees and three manufacturing facilities, and operates two distinct but complementary business units (FMI and Flexan). FMI delivers clean-room manufactured silicone rubber molded components for use in Class II disposable and Class III implantable medical devices. Flexan is a custom molder whose expertise in molding difficult geometries and bonding rubber to metal has earned the company the reputation as an innovative provider across numerous attractive healthcare and industrial markets.  For more information, please visit www.flexan.com and www.fmimed.com.

About Medron Inc. 

Since 1994, MEDRON has successfully served the outsourcing needs of medical device companies around the world. MEDRON has attracted and maintains loyal customers who rely on us for a wide range of outsourcing services, including high volume manufacturing, customer private label capability, design engineering, product development, and prototyping. MEDRON has extensive working expertise in a wide range of materials, including medical grade urethanes, silicones and engineering thermoplastics. Using state-of-the-art machinery, MEDRON creates unique solutions that meet a wide range of customer fabrication needs.  For more information, please visit www.medroninc.com.

About Linden Capital Partners

Linden Capital Partners is a Chicago-based private equity firm focused exclusively on leveraged buyouts in the healthcare and life sciences industries. Linden’s strategy is based upon three elements: (i) healthcare and life science industry specialization, (ii) integrated private equity and operating expertise, and (iii) strategic relationships with large corporations. Linden invests in middle market platforms in the medical products, specialty distribution, pharmaceutical, and services segments of healthcare. For more information, please visit www.lindenllc.com.

For more information, please contact Mike Huiras at Mike.Hurias@flexan.com or (773) 930-4969.